SPOTLIGHT: FiercePharma's Top 10 Articles of 2007


Since FiercePharma was launched in August we've published hundreds of articles, but there are some that are clear favorites with our readers. Check out this list of our most read articles in 2007 to find out which reports FiercePharma readers liked best. List

Suggested Articles

Alnylam is ready to follow on its Onpattro launch with an FDA nod for Givlaari. But the drug's safety profile is giving analysts reason to pause.

FDA nominee Stephen Hahn faced questions from Senators on Wednesday on topics including drug pricing, biosimilars, opioids and more.

BMS’ Opdivo-Yervoy combo been game-changing in late-stage melanoma. But when it comes to expanding the pair’s reach, the company has hit a roadblock.